Literature DB >> 19056296

Rationally designed peptide regulators of protein kinase C.

Eric N Churchill1, Nir Qvit, Daria Mochly-Rosen.   

Abstract

Protein-protein interactions sequester enzymes close to their substrates. Protein kinase C (PKC) is one example of a ubiquitous signaling molecule with effects that are dependent upon localization. Short peptides derived from interaction sites between each PKC isozyme and its receptor for activated C kinase act as highly specific inhibitors and have become available as selective drugs in basic research and animal models of human diseases, such as myocardial infarction and hyperglycemia. Whereas the earlier inhibitory peptides are highly specific, we believe that peptides targeting additional interactions between PKC and selective substrates will generate even more selective tools that regulate different functions of individual isozymes. Here, we discuss the methodologies and applications for identifying selective regulators of PKC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056296      PMCID: PMC2714361          DOI: 10.1016/j.tem.2008.10.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  118 in total

1.  Characterization of the binding and phosphorylation of cardiac calsequestrin by epsilon protein kinase C.

Authors:  M M Rodriguez; C H Chen; B L Smith; D Mochly-Rosen
Journal:  FEBS Lett       Date:  1999-07-09       Impact factor: 4.124

2.  RACK1 binds to inositol 1,4,5-trisphosphate receptors and mediates Ca2+ release.

Authors:  Randen L Patterson; Damian B van Rossum; Roxanne K Barrow; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

3.  Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7).

Authors:  L Chen; L R Wright; C H Chen; S F Oliver; P A Wender; D Mochly-Rosen
Journal:  Chem Biol       Date:  2001-12

4.  Dynamics of glucose-induced localization of PKC isoenzymes in pancreatic beta-cells: diabetes-related changes in the GK rat.

Authors:  Nasim Warwar; Suad Efendic; Claes-Göran Ostenson; Esther P Haber; Erol Cerasi; Rafael Nesher
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

5.  Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C.

Authors:  E G Stebbins; D Mochly-Rosen
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

6.  A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy.

Authors:  Jacob P Lalezari; Joseph J Eron; Margrit Carlson; Calvin Cohen; Edwin DeJesus; Roberto C Arduino; Joel E Gallant; Paul Volberding; Robert L Murphy; Fred Valentine; Emily L Nelson; Prakash R Sista; Alex Dusek; J Michael Kilby
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

7.  C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo.

Authors:  D Ron; J Luo; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

8.  Direct binding and activation of protein kinase C isoforms by aldosterone and 17beta-estradiol.

Authors:  Rodrigo Alzamora; Laura R Brown; Brian J Harvey
Journal:  Mol Endocrinol       Date:  2007-07-31

9.  Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.

Authors:  Masashi Tanaka; Raya D Terry; Golnaz K Mokhtari; Koichi Inagaki; Tomoyoshi Koyanagi; Theo Kofidis; Daria Mochly-Rosen; Robert C Robbins
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

10.  Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function.

Authors:  R Prekeris; M W Mayhew; J B Cooper; D M Terrian
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

View more
  42 in total

1.  Polypeptide modulators of caspase recruitment domain (CARD)-CARD-mediated protein-protein interactions.

Authors:  Yadira Palacios-Rodríguez; Guillermo García-Laínez; Mónica Sancho; Anna Gortat; Mar Orzáez; Enrique Pérez-Payá
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 2.  Fishing for the hidden peptidome in health and disease (drug abuse).

Authors:  Lloyd D Fricker; Jonathan V Sweedler
Journal:  AAPS J       Date:  2010-09-18       Impact factor: 4.009

3.  Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor.

Authors:  Rita Selvatici; Francesco Congestrì; Giuliano Marzola; Remo Guerrini; Anna Siniscalchi; Susanna Spisani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-20       Impact factor: 3.000

Review 4.  Protein kinase C mechanisms that contribute to cardiac remodelling.

Authors:  Alexandra C Newton; Corina E Antal; Susan F Steinberg
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

5.  A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.

Authors:  Christiane B de Araujo; Lilian C Russo; Leandro M Castro; Fábio L Forti; Elisabete R do Monte; Vanessa Rioli; Fabio C Gozzo; Alison Colquhoun; Emer S Ferro
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

6.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

7.  Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.

Authors:  Paul A Wender; Jeremy L Baryza; Stacey E Brenner; Brian A DeChristopher; Brian A Loy; Adam J Schrier; Vishal A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

8.  A new cell-penetrating peptide that blocks the autoinhibitory XIP domain of NCX1 and enhances antiporter activity.

Authors:  Pasquale Molinaro; Anna Pannaccione; Maria José Sisalli; Agnese Secondo; Ornella Cuomo; Rossana Sirabella; Maria Cantile; Roselia Ciccone; Antonella Scorziello; Gianfranco di Renzo; Lucio Annunziato
Journal:  Mol Ther       Date:  2014-12-11       Impact factor: 11.454

9.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.